Abstract
The article reports on the efficacy of sunitinib for thyroid carcinoma from a phase II trial.
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Comment
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Carcinoma, Medullary / drug therapy*
-
Humans
-
Indoles / therapeutic use*
-
Pyrroles / therapeutic use*
-
Sunitinib
-
Thyroid Neoplasms / drug therapy*
Substances
-
Antineoplastic Agents
-
Indoles
-
Pyrroles
-
Sunitinib